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A multilayer stent in the aorta may not seal the
aneurysm, thereby leading to rupture
Andreas M. Lazaris, MD, Anastasios N. Maheras, MD, and Spyros N. Vasdekis, MD, PhD, Athens, Greece
The multilayer stents are occasionally used for the treatment of complicated aortic aneurysms, including thoracoabdomi-
nal aneurysms. No aneurysm-related mortality among patients treated with this technique has been described in the
literature to date. We describe a case of rupture of an aortic aneurysm previously treated with a multilayer stent. ( J Vasc
Surg 2012;56:829-31.)
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mThe use of endografts for the treatment of aortic aneu-
rysmal disease is limited to patients with suitable anatomy.
When the aneurysm is adjacent to or involves a major
arterial branch, available options include open repair and
fenestrated/branched endografts.1 Recently, a new type of
multilayer self-expanding stent technology has been devel-
oped. The Multilayer Aneurysm Repair System (MARS)
developed by Cardiatis, Isne, Belgium, consists of a three-
dimensional braided-wire tube structured in several inter-
locked layers. This three-dimensional geometrical structure
is supposed to give several hemodynamic and biologic
effects that lead to exclusion of the aneurysm sac by leaving
patent any side branches coming out of it.2 Its use is shown
to be effective in occluding peripheral and visceral aneu-
rysms.3-8 Recently, a few references and some anecdotal
studies are proposing MARS as a therapeutic alternative for
the treatment of complex aortic aneurysms.2,3,6,9-12 No
failure of these devices, in term of aneurysm rupture, has
been reported to date. We report a case of a patient with a
suprarenal aortic aneurysm having been treated withMARS
that finally developed an aneurysm rupture.
CASE REPORT
An 82-year-old male patient was urgently transferred by a
district hospital in our institution, with the diagnosis of abdominal
aortic aneurysm rupture. The patient suffered severe abdominal
pain and hemodynamic instability. His medical history included an
open infrarenal abdominal aortic aneurysm repair about 10 years
ago, and an endovascular repair of a suprarenal aortic aneurysm
(probably a proximal para-anastomotic aneurysm), withMARS, 12
months ago. Both procedures had been performed in other insti-
tutions. The emergency computed tomography (CT) scan showed
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http://dx.doi.org/10.1016/j.jvs.2012.03.252ARS extended well above and below the aneurysm area, with
ood and long landing zones. Although the stent permitted flow
o all visceral arteries, the aneurysm sac was also filled by contrast.
dditionally, a contained rupture had existed on the left retroper-
toneal space (Fig 1, A). On an earlier CT scan 6 months before
about 6 months after the stent insertion), blood flow through the
tent system into the aneurysm sac was also noted (Fig 1, B).
The patient was treated with an emergency open repair
hrough a left retroperitoneal approach (Fig 2, A). Because of the
xtended hematoma, the proximal aortic cross-clamping was
chieved at the distal thoracic aorta through a separate left lateral
horacotomy. Although a tube polyester graft was anastomosed
rom the suprarenal aorta to the old aortic graft, the patient
uffered a ventricular tachycardia that led to intraoperative demise.
fter its retrieval, the stent system was inspected and palpated for
ny technical defect, but nothing was found.
ISCUSSION
The hypothesis of aneurysm thrombosis using a low
orosity bare metal stent, a concept similar to MARS, was
rst described about two decades ago. Geremia et al13 had
bserved that a metallic stent when bridging an aneurysmal
ac might alter the flow pattern within the aneurysm,
hereby promoting thrombus formation and aneurysmal
cclusion. At the same time, Piquet et al14 described treat-
ent of aneurysms utilizing a stent-like device that com-
ined both metal and fabric, or so-called “coknit.” In
atients treated with coknit, thrombosis of abdominal aor-
ic aneurysms had been observed, keeping patent the infe-
ior mesenteric artery and some lumbar arteries, similar to
he way stents preserve collateral vessels when placed across
he ostia. MARS is a bare stent system made of biocompat-
ble cobalt alloy wire, structured in several superimposed
ayers, thus achieving low porosity.6 In an aneurysm with
ranches, the stent redirects the flow toward the ostium of
he collaterals by creating a kind of suction effect. Conse-
uently, the aneurysm gradually shrinks while keeping the
ollaterals patent.6
Sporadic recent reports refer to use ofMARS in treating
arious types of aortic aneurysms.6,9-12 In all cases, authors
eport a reduction but not a cessation of blood flow within
he aneurysm sac, which, however, results in gradual aneu-
ysm shrinkage. Despite the fact that blood flow may re-
ain in the aneurysm sac for a variable period of time, no
neurysm-related death attributable to rupture has been
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September 2012830 Lazaris et alreported to date. Recently, Vaislic et al2 reported their
anecdotal experience in treating 29 patients with thoraco-
abdominal aneurysms using MARS. It regarded a multi-
center prospective study that took place in France, in 22
patients suffering thoracoabdominal aortic aneurysms. The
study preceded a pilot study performed in North Africa of
seven similar patients. The total technical success of the
method (defined as aneurysm thrombosis and shrinkage)
was 40%, at 6 months after the procedure whereas in the
pilot study group it was 67% and 83% at 6 and 12 months,
respectively, but no rupture was stated. Failure of total sac
thrombosis was also noted in our case. Although all
splanchnic vessels remained patent, blood flow existed into
the aneurysmal sac at 6 months and 12 months after system
implantation. Unfortunately, this situation led to aneurysm
enlargement and finally to rupture that proved to be lethal.
We believe that when persisting flow into the sac is ob-
served for a long time after MARS implantation, and espe-
cially if the aneurysm does not shrink, other measures
should be undertaken as the situation may become danger-
ous. We believe that if our patient had an elective open
Fig 1. A, Emergency computed tomography (CT) scan:
the intraluminal stent, and left retroperitoneal hematom
insertion: The stent is well extended above and below the
stent into the aortic sac (right short arrow). Flow is shown
arrow).
Fig 2. A, Intraoperative image: through a left retrop
multilayer stent is shown deep inside (black arrow). B, Trepair of his endoleak earlier, he might have had a better futcome. Seeking an explanation of the type of endoleak
hrough MARS that led to aneurysm rupture, we con-
luded that this was not a type I endoleak, as the stent had
een deployed well above and below the aneurysm, with
ong proximal and distal necks (Fig 1, B). Additionally, no
ype III endoleak could be considered, as no defect of the
tent system was noted either on the CT scan or on the
tent itself after its retrieval, thereby leaving the only possi-
le explanation of the leakage, the porosity throughout the
etal mesh of the stent (type IV endoleak).
Based on the operative findings of our case, we came to
ome technical observations:
(1) MARSmay be difficult to be removed in its entirety
ue to its rigid configuration, thereby needing to be di-
ided and removed in pieces.
(2) As the stent seems to strongly adhere at the aortic
all, if it needs to be removed, a safe option would be by
eaving a part of it in place and suturing the new graft with
oth the remaining stent and the native aorta. This tech-
ique was used in our case, and we considered the result
ewarding, as the construction of the anastomosis was
renal aortic aneurysmwith contrast inside the sac outside
hite arrow). B, CT scan 6 months post-primary stent
ysm (long white arrows), but contrast passes through the
gh the stent into the superiormesenteric artery (left short
eal approach, the aneurysmal sac is opened and the
ultilayer stent after its explantation.para
a (w
aneur
throueritoneasible and relatively blood-tight.
11
1
1
1
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 3 Lazaris et al 831(3) Severe fibrosis seems to be created along the peri-
aortic area above the aneurysm where MARS is extended.
In this situation, to achieve proximal aortic control, it
might be safer to dissect in a healthy proximal part of the
aorta away from the stent, such as the distal descending
thoracic aorta.
MARS may be considered a promising solution for
treating complex aortic aneurysms. However, the issue of
blood flow persistence inside the aneurysmal sac has not
completely been solved, keeping the aneurysm enlarge-
ment and rupture a probability. Further laboratory and in
vivo animal studies might be needed before proceeding to
applying the method in large-scale human populations.
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